期刊文献+

皮肤外用他克莫司治疗白癜风 被引量:7

Therapeutic Effect of Topical Taerolimus in Vitiligo Treatment
下载PDF
导出
摘要 他克莫司是一种强效大环内酯类免疫抑制剂,随着其外用制剂的产生,越来越广泛地用于皮肤病的治疗,其中治疗特应性皮炎已较为成熟。在白癜风的治疗中也取得了一定的成效,且由于其局部不良反应小,耐受性高,有较好的应用前景,由于缺乏随机、双盲、对照的临床试验,他克莫司在白癜风治疗中与疾病类型的关系,是否还存在尚未发现的不良反应及长期使用系统吸收是否导致全身不良反应,仍需做进一步的研究。 Tacrolimus is a potent macrolide immunosupressant. With the development of topical preparation of tacrolimus, it is widely used in the treatment of skin diseases, and has been successfully used in atopic dermatitis. Also, because of its safety and high tolerance, it is expected to be used in vitiligo treatment. Since lack of randomized, double-blind and controlled clinical trials, large sample research is still required to investigate the relationship between the drug and clinical types of vitiligo, potential adverse reaction, systemic side effects due to long-term treatment, etc.
作者 林晓 傅雯雯
出处 《国际皮肤性病学杂志》 2006年第4期205-207,共3页 International Journal of Dermatology and Venereology
关键词 他克莫司 白癜风 药物疗法 Tacrolimus Vitiligo Drug therapy
  • 相关文献

参考文献20

  • 1Kovacs SO.Vitiligo.J Am Acad Dermatol,1998,38(5 Pt 1):647-666.
  • 2Caixia T,Hongwen F,Xiran L.Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo.J Dermatol Sci,1999,21:59-62.
  • 3Wang X,Erf GF.Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.J Autoimmun,2004,22:21-30.
  • 4Wang X,Erf GF.Melanocyte-specific cell mediated immune response in vitiliginous Smyth line chickens.J Autoimmun,2003,21:149-160.
  • 5Austin LM,Boissy RE.Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens.An avian model for human vitiligo.Am J Pathol,1995,146:1529-1541.
  • 6Ruzicka T,Assmann T,Homey B.Tacrolimus:the drug for the turn of the millennium? Arch Dermatol,1999,135:574-580.
  • 7Marsland AM,Griffiths CE.The macrolide immunosuppressants in dermatology:mechanisms of action.Eur J Dermatol,2002,12:618-622.
  • 8Cheer SM,Plosker GL.Tacrolimus ointment.A review of its therapeutic potential as a topical therapy in atopic dermatitis.Am J Clin Dermatol,2001,2:389-406.
  • 9Nghiem P,Pearson G,Langley RG.Tacrolimus and pimecrolimus:from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.J Am Acad Dermatol,2002,46:228-241.
  • 10Wollenberg A,Sharma S,von BubnoffD,et al.Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.J Allergy Clin Immunol,2001,107:519-525.

同被引文献16

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部